Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02784158
Title An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung Cancer
Recruitment No longer available
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Ariad Pharmaceuticals
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST